Granted Patent
B2
US 8,912,335 · App. 13/515,508 · Granted Dec 16, 2014
PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases
Inventors:
Gerard R. Colca (Kalamazoo, MI); Steven P. Tanis (Carlsbad, CA); Scott D. Larsen (South Lyon, MI)
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to novel salts of thiazolidinediones and other pharmaceutical agents that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease).
Claims (1)
1. A sodium salt of a compound having the structure:
Assignments (5)
CHANGE OF NAME
Recorded May 12, 2017
From: OCTETA THERAPEUTICS, LLC
To: CIRIUS THERAPEUTICS, INC.
Reel/Frame 042457/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 23, 2016
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: OCTETA THERAPEUTICS, LLC
Reel/Frame 038996/0394 →
RELEASE OF SECURITY INTEREST
Recorded May 19, 2016
From: PACIFIC WESTERN BANK (AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK)
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 038652/0097 →
SECURITY AGREEMENT
Recorded Feb 5, 2014
From: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
To: SQUARE 1 BANK
Reel/Frame 032162/0330 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 13, 2012
From: COLCA, GERARD R.; TANIS, STEVEN P.; LARSEN, SCOTT D.
To: METABOLIC SOLUTIONS DEVELOPMENT COMPANY, LLC
Reel/Frame 028951/0266 →
Continuity (2)
Provisional Application
61286765
· Dec 15, 2009